Amplio Pharma now planning a phase 2a study after NovoBioJect raised intracellular active methotrexate levels by 38%.
|Slideshows|September 6, 2018
Pro-inflammatory Diet Increases Risk of RA in Younger Adults
Foods that promote inflammation can raise the risk of seropositive RA in younger women but not in those older than age 55.
Advertisement
Reference1. Sparks JA, Barbhaiya M, Tedeschi SK, et al. Inflammatory dietary pattern and risk of developing rheumatoid arthritis in women. Clin Rheumatol. 2018 Aug 14. doi: 10.1007/s10067-018-4261-5. [Epub ahead of print]
Advertisement
Related to this article
The EC approved upadacitinib for active polyarticular JIA in children 2 years and older, based on phase 1 SELECT-YOUTH efficacy and safety data.
August 2026 rheumatology highlights include FDA approval of brepocitinib for dermatomyositis and garetosmab-grts for FOP, and new trial data.
In RA-BRIDGE and RA-BRANCH, baricitinib failed to demonstrate VTE noninferiority in patients with RA enriched for thromboembolic risk factors.
A Phase 2a basket trial produced ACR50 responses in 71% of refractory RA patients at 6 months.
Advertisement
Advertisement